Medtronic’s Corevalve Shows Subclavian Access Success In Patients Contraindicated For Femoral Approach

May 22, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Medical News Today -- Medtronic, Inc. announced new data presented today on the safety and effectiveness of Medtronic’s CoreValve system via a novel, subclavian approach.

Twitter
LinkedIn
Facebook
Email
Print